ABO Blood Group and the Risk and Prognosis of Lymphoma

References

• Yamamoto F. Molecular genetics of ABO. Vox Sang. 2000;78(Suppl 2):91–103.
   Google Scholar
• Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev. 2012;26:103–118. doi:10.1016/j.tmrv.2011.08.002
   PubMed Web of Science ®Google Scholar
• Lowe JB. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol. 1993;6:465–492. doi:10.1016/S0950-3536(05)80155-6
   PubMedGoogle Scholar
• Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med. 2013;51:1545–1553. doi:10.1515/cclm-2013-0168
   PubMed Web of Science ®Google Scholar
• Li HY, Guo K. Blood group testing. Front Med. 2022;9:827619. doi:10.3389/fmed.2022.827619
   Web of Science ®Google Scholar
• Oriol R, Mollicone R, Coullin P, Dalix AM, Candelier JJ. Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMIS Suppl. 1992;27:28–38.
   Google Scholar
• Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion. 1998;38:975–988. doi:10.1046/j.1537-2995.1998.381098440863.x
   PubMed Web of Science ®Google Scholar
• Breimer ME, Molne J, Norden G, Rydberg L, Thiel G, Svalander CT. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation. 2006;82:479–485. doi:10.1097/01.tp.0000231697.15817.51
   PubMed Web of Science ®Google Scholar
• Hartmann O, Stavem P. Abo blood-groups and cancer. Lancet. 1964;1:1305–1306. doi:10.1016/S0140-6736(64)91696-4
   Web of Science ®Google Scholar
• Pelzer U, Klein F, Bahra M, et al. Blood group determinates incidence for pancreatic cancer in Germany. Front Physiol. 2013;4:118. doi:10.3389/fphys.2013.00118
   Web of Science ®Google Scholar
• Li X, Xu H, Gao P. ABO blood group and diabetes mellitus influence the risk for pancreatic cancer in a population from China. Med Sci Monit. 2018;24:9392–9398. doi:10.12659/MSM.913769
   Web of Science ®Google Scholar
• Chen Y, Hu N, Liao L, et al. ABO genotypes and the risk of esophageal and gastric cancers. BMC Cancer. 2021;21:589. doi:10.1186/s12885-021-08334-1
   Web of Science ®Google Scholar
• Hakomori S. Fucolipids and blood group glycolipids in normal and tumor tissue. Prog Biochem Pharmacol. 1975;10:167–196.
   Google Scholar
• Hakomori S, Wang SM, Young WW Jr. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with “A-like antigen” in human cancer. Proc Natl Acad Sci U S A. 1977;74:3023–3027. doi:10.1073/pnas.74.7.3023
   PubMed Web of Science ®Google Scholar
• Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999;1473:247–266. doi:10.1016/S0304-4165(99)00183-X
   PubMed Web of Science ®Google Scholar
• Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev. 2000;14:291–301. doi:10.1053/tmrv.2000.16228
   Web of Science ®Google Scholar
• Huang JY, Wang R, Gao YT, Yuan JM. ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study. PLoS One. 2017;12:e0184295. doi:10.1371/journal.pone.0184295
   PubMed Web of Science ®Google Scholar
• Melzer D, Perry JR, Hernandez D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008;4:e1000072. doi:10.1371/journal.pgen.1000072
   PubMed Web of Science ®Google Scholar
• Nieters A, Yuan JM, Sun CL, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005;103:740–748. doi:10.1002/cncr.20842
   PubMed Web of Science ®Google Scholar
• Gocer M, Kurtoglu E. Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma. Memo. 2021;14:235–240. doi:10.1007/s12254-020-00669-y
   Google Scholar
• Barlogie B, Smallwood L, Smith T, Alexanian R. High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma. Ann Intern Med. 1989;110:521–525. doi:10.7326/0003-4819-110-7-521
   PubMed Web of Science ®Google Scholar
• Stellner K, Hakomori S, Warner GS. Enzymic conversion of “H1-glycolipid” to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma. Biochem Biophys Res Commun. 1973;55:439–445. doi:10.1016/0006-291X(73)91106-6
   PubMed Web of Science ®Google Scholar
• Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M. ABH and Lewis histo-blood group antigens in cancer. APMIS. 2001;109:9–31. doi:10.1111/j.1600-0463.2001.tb00011.x
   PubMed Web of Science ®Google Scholar
• Dabelsteen E, Gao S. ABO blood-group antigens in oral cancer. J Dent Res. 2005;84:21–28. doi:10.1177/154405910508400103
   PubMed Web of Science ®Google Scholar
• Sano R, Nakajima T, Takahashi K, et al. Expression of ABO blood-group genes is dependent upon an erythroid cell-specific regulatory element that is deleted in persons with the B(m) phenotype. Blood. 2012;119:5301–5310. doi:10.1182/blood-2011-10-387167
   Web of Science ®Google Scholar
• Hayakawa A, Sano R, Takahashi Y, et al. RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen. Transfusion. 2020;60:184–196. doi:10.1111/trf.15628
   Web of Science ®Google Scholar
• Kronstein-Wiedemann R, Nowakowska P, Milanov P, et al. Regulation of ABO blood group antigen expression by miR-331-3p and miR-1908-5p during hematopoietic stem cell differentiation. Stem Cells. 2020;38:1348–1362. doi:10.1002/stem.3251
   Web of Science ®Google Scholar
• Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G. von Willebrand factor and cancer: a renewed interest. Thromb Res. 2013;131:290–292. doi:10.1016/j.thromres.2013.01.015
   Web of Science ®Google Scholar
• Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14:434–440. doi:10.2450/2015.0164-15
   PubMed Web of Science ®Google Scholar
• O’Sullivan JM, Preston RJS, Robson T, O’Donnell JS. Emerging roles for von Willebrand factor in cancer cell biology. Semin Thromb Hemost. 2018;44:159–166. doi:10.1055/s-0037-1607352
   Web of Science ®Google Scholar
• Ibrahim-Kosta M, Bailly P, Silvy M, et al. ABO blood group, glycosyltransferase activity and risk of venous thromboembolism. Thromb Res. 2020;193:31–35. doi:10.1016/j.thromres.2020.05.051
   Web of Science ®Google Scholar
• Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010;19:1863–1872. doi:10.1093/hmg/ddq061
   PubMed Web of Science ®Google Scholar
• Kiechl S, Pare G, Barbalic M, et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet. 2011;4:681–686. doi:10.1161/CIRCGENETICS.111.960682
   PubMedGoogle Scholar
• Fernandes JV, Cobucci RN, Jatoba CA, Fernandes TA, de Azevedo JW, de Araujo JM. The role of the mediators of inflammation in cancer development. Pathol Oncol Res. 2015;21:527–534. doi:10.1007/s12253-015-9913-z
   PubMed Web of Science ®Google Scholar
• Singh R, Mishra MK, Aggarwal H. Inflammation, Immunity, and Cancer. Mediators Inflamm. 2017;2017:6027305. doi:10.1155/2017/6027305
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Orlow I, Lacombe L, Pellicer I, et al. Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer. 1998;75:819–824. doi:10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y
   Web of Science ®Google Scholar
• Iwamoto S, Withers DA, Handa K, Hakomori S. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj J. 1999;16(10):659–666. doi:10.1023/A:1007085202379
   Web of Science ®Google Scholar
• Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F. Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem. 1999;274:37240–37250. doi:10.1074/jbc.274.52.37240
   Google Scholar
• Gao S, Bennett EP, Reibel J, et al. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization. APMIS. 2004;112:11–20. doi:10.1111/j.1600-0463.2004.apm1120103.x
   Web of Science ®Google Scholar
• Ichikawa D, Handa K, Withers DA, Hakomori S. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res. 1997;57:3092–3096.
   Web of Science ®Google Scholar
• Greenwell P. Blood group antigens: molecules seeking a function? Glycoconj J. 1997;14:159–173. doi:10.1023/A:1018581503164
   PubMed Web of Science ®Google Scholar
• Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540–555. doi:10.1038/nrc3982
   PubMed Web of Science ®Google Scholar
• Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473–510. doi:10.1146/annurev-pathol-012414-040438
   PubMed Web of Science ®Google Scholar
• Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346–366. doi:10.1038/s41581-019-0129-4
   PubMed Web of Science ®Google Scholar
• Laubli H, Borsig L. Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis. Front Immunol. 2019;10:2120. doi:10.3389/fimmu.2019.02120
   PubMed Web of Science ®Google Scholar
• Xu Y, Chang R, Xu F, et al. N-glycosylation at Asn 402 stabilizes N-cadherin and promotes cell-cell adhesion of glioma cells. J Cell Biochem. 2017;118:1423–1431. doi:10.1002/jcb.25801
   Web of Science ®Google Scholar
• Scott GL, Rasbridge MR. Loss of blood group antigenicity in a patient with Hodgkin’s disease. Vox Sang. 1972;23:458–460. doi:10.1111/j.1423-0410.1972.tb03836.x
   Web of Science ®Google Scholar
• Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood. 2001;97:3633–3639. doi:10.1182/blood.V97.11.3633
   PubMed Web of Science ®Google Scholar
• Clausen H, Hakomori S, Graem N, Dabelsteen E. Incompatible A antigen expressed in tumors of blood group O individuals: immunochemical, immunohistologic, and enzymatic characterization. J Immunol. 1986;136:326–330. doi:10.4049/jimmunol.136.1.326
   PubMed Web of Science ®Google Scholar
• Metoki R, Kakudo K, Tsuji Y, Teng N, Clausen H, Hakomori S. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. J Natl Cancer Inst. 1989;81:1151–1157.
   Google Scholar
• Ergun Y, Esen SA, Bardakci M, et al. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors. Cancer Biomark. 2022;34:329–336. doi:10.3233/CBM-210455
   Web of Science ®Google Scholar
• Spring FA, Dalchau R, Daniels GL, et al. The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene. Immunology. 1988;64:37–43.
   PubMed Web of Science ®Google Scholar
• Haynes BF, Telen MJ, Hale LP, Denning SM. CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 1989;10:423–428. doi:10.1016/0167-5699(89)90040-6
   PubMedGoogle Scholar
• Akisik E, Bavbek S, Dalay N. CD44 variant exons in leukemia and lymphoma. Pathol Oncol Res. 2002;8:36–40. doi:10.1007/BF03033699
   PubMedGoogle Scholar
• Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol. 2008;18:260–267. doi:10.1016/j.semcancer.2008.03.015
   PubMed Web of Science ®Google Scholar
• Ward SE, O’Sullivan JM, O’Donnell JS. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis. Blood. 2020;136:2864–2874. doi:10.1182/blood.2020005843
   PubMed Web of Science ®Google Scholar
• Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117(3):1071–1080. doi:10.1182/blood-2010-01-264507
   PubMed Web of Science ®Google Scholar
• Ishihara J, Ishihara A, Starke RD, et al. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019;133:2559–2569. doi:10.1182/blood.2019000510
   Web of Science ®Google Scholar
• Collet A, Zawadzki C, Jeanpierre E, et al. ABO blood groups in systemic sclerosis: distribution and association with this disease’s characteristics. J Clin Med. 2022;12:12. doi:10.3390/jcm12010012
   Web of Science ®Google Scholar
• Klove-Mogensen K, Steffensen R, Masmas TN, et al. ABO, secretor, and Lewis carbohydrate histo-blood groups are associated with autoimmune neutropenia of early childhood in Danish patients. Transfusion. 2022;62:1636–1642. doi:10.1111/trf.17002
   Web of Science ®Google Scholar
• Salem GI, Gamal NM, Talaat EA, El-Hammady DH, Hammam N, Gheita TA. Clinical impact of the ABO blood type in patients with rheumatic diseases: is there a link to the ABO and rhesus? Mediterr J Rheumatol. 2021;32:237–242. doi:10.31138/mjr.32.3.237
   Google Scholar
• Stoia I, Ramneantu R, Poitas M. Blood groups ABO and Rh (D) factor in the rheumatic diseases. Ann Rheum Dis. 1967;26:332–333. doi:10.1136/ard.26.4.332
   Web of Science ®Google Scholar
• Nik A, Mirfeizi Z, Rezaieyazdi Z, et al. ABO and Rh blood groups in patients with lupus and rheumatoid arthritis. Caspian J Intern Med. 2021;12:568–572. doi:10.22088/cjim.12.4.568
   Web of Science ®Google Scholar
• Islamoglu ZGK, Unal M. Is there an association of ABO blood groups and Rhesus factor with alopecia areata? J Cosmet Dermatol. 2018;17:1271–1274. doi:10.1111/jocd.12491
   Web of Science ®Google Scholar
• Cildag S, Kara Y, Senturk T. ABO blood groups and rheumatic diseases. Eur J Rheumatol. 2017;4:250–253. doi:10.5152/eurjrheum.2017.17044
   Google Scholar
• Chen J, Chen H, Lin Y, Zheng W, Wang C. Association between ABO blood group and risk of Crohn’s disease: a case-control study in the Chinese Han population. J Clin Lab Anal. 2022;36:e24195. doi:10.1002/jcla.24195
   Web of Science ®Google Scholar
• Forni D, Cleynen I, Ferrante M, et al. ABO histo-blood group might modulate predisposition to Crohn’s disease and affect disease behavior. J Crohns Colitis. 2014;8:489–494. doi:10.1016/j.crohns.2013.10.014
   Web of Science ®Google Scholar
• Dagdeviren M, Ates I, Demir BF, Ergun E, Yildiz C, Altay M. Investigation of blood groups in benign thyroid diseases in Turkey. Endocr J. 2019;66:1001–1009. doi:10.1507/endocrj.EJ18-0582
   Web of Science ®Google Scholar
• Lopetegi I, Munoz-Lopetegi A, Arruti M, et al. ABO blood group distributions in multiple sclerosis patients from Basque Country; O(-) as a protective factor. Mult Scler J Exp Transl Clin. 2019;5:2055217319888957. doi:10.1177/2055217319888957
   Google Scholar
• Markovic S, Bozicevic D, Simic D, Brzovic Z. Genetic markers in the blood of multiple sclerosis patients. Neurol Croat. 1991;41:3–12.
   Google Scholar
• Ye BD, Kim BM, Jung S, et al. Association of FUT2 and ABO with Crohn’s disease in Koreans. J Gastroenterol Hepatol. 2020;35:104–109. doi:10.1111/jgh.14766
   Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med. 2009;265:421–438. doi:10.1111/j.1365-2796.2009.02083.x
   PubMed Web of Science ®Google Scholar
• Enzler T, Gillessen S, Manis JP, et al. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med. 2003;197:1213–1219. doi:10.1084/jem.20021258
   PubMed Web of Science ®Google Scholar
• Vadivelu MK, Damodaran S, Solomon J, Rajaseharan A. Distribution of ABO blood groups in acute leukaemias and lymphomas. Ann Hematol. 2004;83:584–587. doi:10.1007/s00277-004-0888-1
   PubMed Web of Science ®Google Scholar
• Li YJ, Yi PY, Li JW, et al. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study. Chin J Cancer. 2017;36:62. doi:10.1186/s40880-017-0229-0
   Google Scholar
• Osada Y, Ito C, Nishiyama-Fujita Y, et al. Prognostic impact of ABO blood group on survival in patients with malignant lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20:122–129. doi:10.1016/j.clml.2019.09.607
   Web of Science ®Google Scholar
• Li Y, Wang Y, Wang Z, Yi D, Ma S. Racial differences in three major NHL subtypes: descriptive epidemiology. Cancer Epidemiol. 2015;39:8–13. doi:10.1016/j.canep.2014.12.001
   PubMed Web of Science ®Google Scholar
• Vaughn JL, Spies D, Xavier AC, Epperla N. Racial disparities in the survival of patients with indolent non-Hodgkin lymphomas in the United States. Am J Hematol. 2021;96:816–822. doi:10.1002/ajh.26198
   PubMed Web of Science ®Google Scholar
• Bloodbook. Racial and ethnic distribution of ABO blood types. Available from: http://www.bloodbook.com/world-abo.html. Accessed December 06, 2022.
   Google Scholar
• Petrosyan A, Palanjyan A, Melnichenko I, et al. ALL-436 association between ABO and Rh blood groups and pediatric hematological malignances in Armenia. Clin Lymphoma Myeloma Leuk. 2022;22(Suppl 2):S204–S205. doi:10.1016/S2152-2650(22)01204-6
   Google Scholar
• Levitan R, Razis DV, Diamond HD, Craver LF. ABO blood groups in Hodgkin’s disease. Acta Haematol. 1959;22:12–19. doi:10.1159/000205756
   Google Scholar
• Gharouni M, Abouzari M, Rashidi A, Sodagari N, Behzadi M. Low frequency of blood group A in primary central nervous system lymphoma. J Neurooncol. 2008;87:363–364. doi:10.1007/s11060-008-9516-6
   Web of Science ®Google Scholar
• Abouzari M, Behzadi M, Rashidi A. Low frequency of blood group A in secondary central nervous system lymphoma. Surg Neurol Int. 2012;3:95. doi:10.4103/2152-7806.100179
   Google Scholar
• Williams AO. Haemoglobin genotypes, ABO blood groups, and Burkitt’s tumour. J Med Genet. 1966;3:177–179. doi:10.1136/jmg.3.3.177
   Google Scholar
• Saichua S, Chiewsilp P. Red cell ABH antigens in leukaemias and lymphomas. Vox Sang. 1978;35:154–159. doi:10.1111/j.1423-0410.1978.tb02915.x
   Web of Science ®Google Scholar
• Janardhana V, Propert DN, Green RE. ABO blood groups in hematologic malignancies. Cancer Genet Cytogenet. 1991;51:113–120. doi:10.1016/0165-4608(91)90016-N
   PubMed Web of Science ®Google Scholar
• Tizro P, Liu ML, Aggarwal A, Nava VE. ABO blood group as a prognostic factor in patients with diffuse large B cell lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20:561–562. doi:10.1016/j.clml.2020.03.001
   Google Scholar
• Oberhuber G, Kranz A, Dejaco C, et al. Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma. Gut. 1997;41:37–42. doi:10.1136/gut.41.1.37
   Web of Science ®Google Scholar
• Ulu BU, Basci S, Bakirtas M, et al. Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma? Leuk Res. 2022;115:106810. doi:10.1016/j.leukres.2022.106810
   Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar